Dual orexin receptor antagonists as promising therapeutics for Alzheimer’s disease

被引：0

作者：

S. M. Ragsdale ^{[1
]}

J. M. Radovich ^{[2
]}

I. I. Coiduras ^{[3
]}

W. V. McCall ^{[1
]}

S. C. Grant ^{[4
]}

C. Lee ^{[2
]}

A. Wilber ^{[3
]}

机构：

[1] Department of Psychology; Program in Neuroscience; Florida State University,Department of Chemical & Biochemical Engineering, FAMU

[2] Florida State University,FSU College of Engineering

[3] Florida State University,CIMAR, National High Magnetic Field Laboratory

[4] Department of Psychiatry and Health Behavior; Medical College of Georgia; Augusta University,Department of Biomedical Sciences; Program in Neuroscience; College of Medicine

[5] Florida State University,undefined

来源：

npj Biological Timing and Sleep | / 2卷 / 1期

关键词：

D O I：

10.1038/s44323-025-00025-5

中图分类号：

学科分类号：

摘要：

We examine the relationship between sleep, glymphatics and Alzheimer’s disease (AD), and recent work questioning glymphatic clearance during sleep. We highlight a need for understanding glymphatic and/or other mechanism of clearance during sleep, and review glymphatic flow measurement methods. Further, we explore dual orexin receptor antagonists (DORAs) potential to mitigate AD sleep disturbances and enhance clearance. Further research could elucidate a linkage between DORAs, improved sleep and reducing AD pathophysiology.

引用

共 50 条

[1] An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics
Janto, Kayla
Prichard, J. Roxanne
Pusalavidyasagar, Snigdha
JOURNAL OF CLINICAL SLEEP MEDICINE, 2018, 14 (08): : 1399 - 1408
[2] Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders
Palasz, Artur
Lapray, Damien
Peyron, Christelle
Rojczyk-Golebiewska, Ewa
Skowronek, Rafal
Markowski, Grzegorz
Czajkowska, Beata
Krzystanek, Marek
Wiaderkiewicz, Ryszard
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (01): : 157 - 168
[3] Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders
Carpi, Matteo
Mercuri, Nicola Biagio
Liguori, Claudio
DRUGS, 2024, : 1365 - 1378
[4] Discovery and development of orexin receptor antagonists as therapeutics for insomnia
Winrow, C. J.
Renger, J. J.
BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (02) : 283 - 293
[5] Effect of a dual orexin receptor antagonist on Alzheimer's disease: Sleep disorders and cognition
Zhou, Mengzhen
Tang, Shi
FRONTIERS IN MEDICINE, 2023, 9
[6] IDENTIFICATION OF POTENT DUAL OREXIN RECEPTOR ANTAGONISTS
Coleman, Paul J.
Schreier, John D.
Cox, Christopher D.
Breslin, Michael J.
Whitman, David B.
Roecker, Anthony J.
Bogusky, Michael J.
Bednar, Rodney A.
Lemaire, Wei
Bruno, Joseph C.
Hartman, George D.
McGaughey, Georgia B.
Reiss, Duane R.
Harrell, C. Meacham
Doran, Scott M.
Garson, Susan L.
Kraus, Richard L.
Li, Yuxing
Prueksaritanont, Thomayant
Li, Chunze
Winrow, Christopher J.
Koblan, Kenneth S.
Renger, John J.
DRUGS OF THE FUTURE, 2009, 34 : 10 - 11
[7] Therapeutics development for addiction: Orexin-1 receptor antagonists
Perrey, David A.
Zhang, Yanan
BRAIN RESEARCH, 2020, 1731
[8] Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists
Skudlarek, Jason W.
DiMarco, Christina N.
Babaoglu, Kerim
Roecker, Anthony J.
Bruno, Joseph G.
Pausch, Mark A.
O'Brien, Julie A.
Cabalu, Tamara D.
Stevens, Joanne
Brunner, Joseph
Tannenbaum, Pamela L.
Wuelfing, W. Peter
Garson, Susan L.
Fox, Steven V.
Savitz, Alan T.
Harrell, Charles M.
Gotter, Anthony L.
Winrow, Christopher J.
Renger, John J.
Kuduk, Scott D.
Coleman, Paul J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (06) : 1364 - 1370
[9] Orexin and Alzheimer's disease
Liguori, C.
JOURNAL OF SLEEP RESEARCH, 2018, 27
[10] Orexin receptor antagonists: a review of promising compounds patented since 2006
Coleman, Paul J.
Renger, John J.
EXPERT OPINION ON THERAPEUTIC PATENTS, 2010, 20 (03) : 307 - 324

← 1 2 3 4 5 →